Targeting metabolism and AMP-activated kinase with metformin to sensitize non-small cell lung cancer (NSCLC) to cytotoxic therapy: translational biology and rationale for current clinical trials

Lung cancer is the most fatal malignancy worldwide, in part, due to high resistance to cytotoxic therapy. There is need for effective chemo-radio-sensitizers in lung cancer. In recent years, we began to understand the modulation of metabolism in cancer and its importance in tumor progression and sur...

Descripción completa

Detalles Bibliográficos
Autores principales: Troncone, Michael, Cargnelli, Stephanie M., Villani, Linda A., Isfahanian, Naghmeh, Broadfield, Lindsay A., Zychla, Laura, Wright, Jim, Pond, Gregory, Steinberg, Gregory R., Tsakiridis, Theodoros
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5593680/
https://www.ncbi.nlm.nih.gov/pubmed/28915708
http://dx.doi.org/10.18632/oncotarget.17496

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5593680/
https://www.ncbi.nlm.nih.gov/pubmed/28915708
http://dx.doi.org/10.18632/oncotarget.17496

Ejemplares similares